Synonymous single-nucleotide variants (SNVs), although they do not alter the encoded protein sequences, have been implicated in many genetic diseases. Experimental studies indicate that synonymous SNVs can lead to changes in the secondary and tertiary structures of DNA and RNA, thereby affecting translational efficiency, cotranslational protein folding as well as the binding of DNA-/RNA-binding proteins. However, the importance of these various features in disease phenotypes is not clearly understood. Here, we have built a support vector machine (SVM) model (termed DDIG-SN) as a means to discriminate disease-causing synonymous variants. The model was trained and evaluated on nearly 900 disease-causing variants. The method achieves robust performance with the area under the receiver operating characteristic curve of 0.84 and 0.85 for protein-stratified 10-fold cross-validation and independent testing, respectively. We were able to show that the disease-causing effects in the immediate proximity to exon-intron junctions (1-3 bp) are driven by the loss of splicing motif strength, whereas the gain of splicing motif strength is the primary cause in regions further away from the splice site (4-69 bp). The method is available as a part of the DDIG server at http://sparks-lab.org/ddig.
INTRODUCTION
Synonymous variants (also called silent or same-sense mutations) are single-nucleotide variants (SNVs) that result in synonymous codon substitutions (a codon encoding a specific amino acid residue is replaced by another codon encoding the same amino acid). Despite not altering the translated protein product, more and more studies have suggested that both germline and somatic synonymous variants may be deleterious and can lead to a number of genetic diseases (Hunt, Simhadri, Iandoli, Sauna, & Kimchi-Sarfaty, 2014; Niroula & Vihinen, 2016; Sauna & Kimchi-Sarfaty, 2011; Shabalina, Spiridonov, & Kashina, 2013) including cancer (Supek, Minana, Valcarcel, Gabaldon, & Lehner, 2014) , autism spectrum disorders (Neale et al., 2012; Samocha et al., 2014) , asthma, and osteoporosis (Macaya et al., 2009) , as well as increasing disease susceptibility to idiopathic dilated cardiomyopathy (Stark et al., 2010) , altering disease outcome in pediatric acute myeloid leukemia (Ho et al., 2011) , and creating individualized responses to drugs by affecting the function of drug transporters (Kimchi-Sarfaty et al., 2007) . The number of known disease-causing synonymous variants has been steadily increasing in recent years, as is evidenced by a 16% increase in the number of pathogenic synonymous variants recorded in the Human Gene Mutation Database (HGMD) (Stenson et al., 2017) over the last 15 months (from 1,181 to 1,368 in the HGMD versions 2015.3 and 2016.4, respectively) .
Synonymous variants alter the sequences of DNA and their corresponding messenger RNA (mRNA) transcripts. One direct consequence of the sequence change is the altered codon. Codon usage (termed "codon bias") has long been known to affect gene expression, translation velocity, and folding efficiency (Hershberg & Petrov, 2008; Plotkin & Kudla, 2011) , although whether or not such codon bias in mammals is caused by evolutionary selection or large variation in GC content (isochores) remains an active subject of debate (Kirchner & Ignatova, 2015; Rudolph et al., 2016) . Sequence change could also modify cytosine-phosphate-guanine (CpG) sites, thereby influencing local chromatin structure and DNA methylation patterns (Deaton & Bird, 2011) . Moreover, coding regions have been found to directly interact with microRNA (Bentwich et al., 2005; Brest et al., 2011; Gartner et al., 2013; Hurst, 2006) as well as with DNA-and RNA-binding proteins (Dreyfuss, Kim, & Kataoka, 2002; Stergachis et al., 2013) . Altering these interactions through sequence variation will affect the regulatory control and outcome of transcription and translation. For example, exonic splicing elements (enhancers and silencers) regulate splicing by interacting with SR proteins and heterogeneous ribonucleoprotein particles, respectively (Zhu, Mayeda, & Krainer, 2001) . At least 4% of synonymous variants have been shown to be deleterious to splicing enhancers (Cáceres & Hurst, 2013; Carlini & Genut, 2006; Fairbrother, Holste, Burge, & Sharp, 2004; Parmley, Chamary, & Hurst, 2006; Savisaar & Hurst, 2017; Wu & Hurst, 2016) . Variant-induced changes to mRNA secondary structure have been found to alter mRNA stability (Chamary & Hurst, 2005; Duan et al., 2013) , hamper protein expression [at least in bacteria (Kudla, Murray, Tollervey, & Plotkin, 2009)] , and affect mRNA splicing (Buratti & Baralle, 2004) , whereas analysis of the solvent-accessible surface area of RNA indicates that rare alleles are more likely to occur in the buried, structured regions of coding RNA . In addition, changing the nucleotide sequence may lead to the formation or disruption of a square-planar structure formed by guanine (Gquadruplex), which has been implicated in both positive and negative transcriptional regulation (Rhodes & Lipps, 2015; Simone, Fratta, Neidle, Parkinson, & Isaacs, 2015) .
Thus, it is clear that a synonymous variant can lead to changes in the structure and function of both the DNA sequence and the mRNA transcript. Consequently, this disrupts regulatory controls and affects the structure and function of the final protein product. Although mRNA splicing accounts for a large proportion (20%-40%) of diseaseassociated SNVs (Wu & Hurst, 2016) , what is not yet clear is the role that other factors might play in mediating the pathogenic influence of disease-causing synonymous variants. SilVA (Buske, Manickaraj, Mital, Ray, & Brudno, 2013) , the first method dedicated to the discrimination of disease-causing synonymous variants, employed a range of features, including evolutionary conservation at the DNA level, codon usage, CpG sites, splicing site motifs, and mRNA folding energy. However, it was trained and tested using a dataset of only 41 disease-causing synonymous variants. Alternatively, methods for the prediction of defects in RNA splicing, including SPANR or SPIDEX (a precomputed index of SPANR scores for the human genome) (Xiong et al., 2015) , MutPred Splice , and ExonImpact , can also be used to study synonymous variants. Other techniques, such as CADD (Kircher et al., 2014) , MutationTaster (Schwarz, Cooper, Schuelke, & Seelow, 2014) , and FATHMM-MKL (Shihab et al., 2015) , provide general frameworks for predicting all types of pathogenic genetic variation (missense, nonsense, synonymous, microinsertions, and microdeletions-"indels") in both coding and noncoding regions.
However, owing to their generality, it is difficult to dissect the relative importance of various features specifically for synonymous variants.
In this work, we investigated the ability of DNA-, RNA-, and proteinbased features to discriminate pathogenic from putatively benign synonymous variants, with or without filtering variants with low minor allele frequencies. We employed a nonredundant training dataset of 318 genes with at least one disease-causing and one putatively benign variant per gene from the HGMD (Stenson et al., 2017 ) and 1000 Genomes Project (1kGP) (1000 Genomes Project Consortium, 2015 , respectively. Analysis at a single feature level as well as crossvalidation and independent testing using an SVM model indicated that the impact on RNA splicing is the dominant factor for diseasecausing synonymous variants, even if evolutionary conservation had been excluded from feature selection.
MATERIALS AND METHODS

Datasets
We compiled two synonymous variant datasets: one for design, crossvalidation, and training of our method and one for independent testing.
The putatively benign variants were derived from the 1kGP, phase 3, version 5b, 20130502 (1000 Genomes Project Consortium, 2015 . The disease-causing variants were retrieved from the HGMD Professional, version 2015.3 (Stenson et al., 2017) , utilizing only the variants labeled as disease-causing ("DM" and "DM?" labels). As a reference transcript set, we used the Consensus CoDing Sequence (CCDS) project, version 20131129 (Pruitt et al., 2009 ).
We first compiled the disease-causing datasets in a mutually independent fashion. To this end, we split the HGMD variants with a ratio of 2:1 for training and testing. We ensured that the split was protein-stratified with a sequence identity threshold of 30%. That is, we ensured low sequence similarity between the genes from the training and test sets. Finally, for every gene, we added the putatively benign 1kGP variants. If there were no benign variants for a given gene, we discarded all disease-causing variants from this gene. Ensuring that every gene had at least one disease-causing and one benign variant has been suggested in order to allow correct learning of variant-specific features rather than gene-related properties (Grimm et al., 2015) .
In a comparison with related work, we found that one of the methods (SilVA) yielded no predictions for two variants (located on the Y chromosome) from our design/training dataset. To facilitate a fair comparison of related work, we removed these two variants from our dataset. Another method (SPIDEX) yielded 2,604 missing predictions for our datasets, mostly because of its limitation to predict splicing effects for variants located only up to 300 nucleotides from splice junctions. We decided to retain these variants in our datasets after checking that the overall ranking of the compared methods was not affected.
As a result of the described procedure, we obtained two mutually independent and protein-stratified datasets. The design/training dataset containing 318 genes with 592 disease-causing and 10,925 putatively benign synonymous variants. This dataset was utilized for design, training, and 10-fold cross-validation of our method. The test set comprised 143 genes with 279 disease-causing and 4,945 benign variants. Finally, we also compiled fully balanced subsets of these datasets where for every disease-causing variant, one benign variant was selected so that the genomic distance between the two was as small as possible. We refer to these datasets as to "close-by" datasets since the subsampling procedure ensured that every selected benign 
Predictive features
We investigated 54 features for discriminating disease-causing and benign synonymous variants at three different levels: DNA, RNA, and protein levels. Out of these 54 features, 26 features were also employed for developing SilVA (Buske et al., 2013) . Supp. Table S1 briefly summarizes all predictive features.
DNA-based features
We derived six new DNA-based features. The feature phyloP cons46 was derived from phylogenetic P values of the multiple sequence alignment (MSA) of 45 vertebrates to the human genome (cons46way) as calculated with the phyloP program (Pollard, Hubisz, Rosenbloom, & Siepel, 2010) . Similarly, using an alignment of 99 vertebrates to the human genome (cons100way) (Karolchik et al., 2004; Miller et al., 2007) , we calculated the allele frequency (AF) of the reference allele (rAF cons100 ) and the difference in the frequencies of the alternative and reference alleles (ΔAF cons100 ). Next, we used DeepBind (Alipanahi, Delong, Weirauch, & Frey, 2015) (Todd, Johnston, & Neidle, 2005) . In addition, we employed another five features from SilVA including DNA conservation score GERP++ cons34 (Davydov et al., 2010) , relative synonymous codon usage (RSCU), variant-induced change in codon usage (|ΔRSCU|) (Sharp & Li, 1987) , variant-induced change in CpG (CpG?), and the ratio of the observed and expected CpG content of the exon (CpG exon ).
RNA-based features
We implemented 11 new RNA-based features. We predicted RNA solvent-accessible surface area (ASA RNA ) of the variant site using RNAsnap trained on experimentally determined protein-RNA complex structures . We predicted the change between the binding affinities (ΔRBP aff ) of the reference and alternative sequences for a set of 53 RNA-binding proteins .
Another feature, SPIDEX ΔΨ , was extracted from the SPIDEX database (Xiong et al., 2015) and is based on the maximum ΔΨ scores across all predicted tissues. ΔΨ expresses the difference between the predicted exon-inclusion probabilities of the reference and alternative sequences. As suggested in Wu and Hurst (2016) , we also examined the location of the exon within the given gene, implemented as the relative exon number feature (the exon number in the 5 ′ -3 ′ direction divided by the number of exons), and the distance to the nearest 5 ′ , 3 ′ or closest splice site (exon-intron junction). Further, we defined a feature termed fraction of unaffected transcripts where an unaffected transcript (splice isoform) is one for which the variant is located within an intron (whereas the variant is located in an exon for some other splice isoforms of the same gene). Finally, we implemented three features based on the consensus dataset of 84 exonic splicing enhancer (ESE) motifs, INT3 (Cáceres & Hurst, 2013) . These three binary features were the loss (ESE loss ), gain (ESE gain ), and loss or gain (ESE loss/gain ) of an INT3 ESE motif due to the introduced variant.
In addition to the features listed above, we implemented 21 features utilized in SilVA. These features include the changes in the secondary structure folding energy of pre-mRNA and mature mRNA calculated with UNAFold (Markham & Zuker, 2008) , changes in the diversity of the structural ensemble of pre-mRNA and mature mRNA obtained using ViennaRNA (Lorenz et al., 2011) , relative distances to the end of pre-mRNA and mature mRNA, various features pertaining to the splice-site motif strength calculated with MaxEntScan , and gain and loss of ESE and exonic splicing silencer motifs based on ESE Finder (Smith et al., 2006) , PESX (Zhang & Chasin, 2004) , and FAS-hex3 (Wang et al., 2004) datasets.
Protein-based features
We implemented 11 protein-based features that were found to be useful for predicting disease-causing indels (Folkman et al., 2015; Zhao et al., 2013) and stability changes induced by single amino acid substitutions (Folkman, Stantic, Sattar, & Zhou, 2016) . Among those, three were related to protein conservation, five to protein structure, and three to global sequence properties. We examined protein conservation scores calculated as Jensen-Shannon divergence (JS cons ) using the available implementation (Capra & Singh, 2007) . We calculated these conservation scores from the MSA generated with PSI-BLAST (NCBI nonredundant database, three iterations, e-value threshold 0.001) (Altschul et al., 1997) . Another protein conservation feature, HHblits cons , was calculated using HHblits (Remmert, Biegert, Hauser, & Soding, 2012) , which searches for similar sequences from the UniProt database (UniProt Consortium, 2015) using hidden Markov model sequence profiles. In addition, we considered the HHblits neff feature, which expresses the number of sequences aligned to the variant site in the HHblits' MSA. Other protein-based features described the relative variant location as a distance to the N-terminal (N-term dist ), C-terminal (C-term dist ), and the center of the sequence (center dist ), divided by the length of the protein sequence. Finally, we considered five proteinlevel structural features predicted from the protein sequence: relative accessible surface area and helix, sheet, coil, and disorder probabilities. The accessible surface area and secondary structure probabilities were predicted with SPIDER2 (Heffernan et al., 2015) , and the disorder probability was calculated using SPINE-D (Zhang et al., 2012) .
Single feature analysis
To analyze the potency of a single feature to discriminate diseasecausing synonymous variants, we randomly subsampled the design/training dataset into 100 balanced samples so that there were exactly the same number of disease-causing and putatively benign variants for each gene (2 × 591 variants in total). Then, we performed protein-stratified 10-fold cross-validation using a single feature. This procedure ensured that the single feature analysis would not be adversely affected by gene-level global properties.
Machine learning
We implemented our method with the SVM algorithm (Cortes & Vapnik, 1995) , which classifies examples (variants) as positive (diseasecausing) or negative (putatively benign) based on the optimal separating hyperline, which is learned from the training data. We used the radial basis function (RBF) kernel to perform a nonlinear transformation of the feature space. To set optimal values of hyper-parameters (namely, the regularization parameter C and RBF width parameter ),
we performed a grid search that spanned across all combinations of C ∈ {2 −5 , 2 −3 , …, 2 11 } and ∈ {2 −11 , 2 −9 , …, 2 −1 }. Because our training dataset was extremely unbalanced with a ratio of 1:18, we set the SVM weight penalty (w) for misclassifying a positive (disease-causing) example to w = 18.
Feature selection
We used the stability selection algorithm (Meinshausen & Buhlmann, 2010) to select a robust combination of predictive features. In our implementation, we exploited the unbalanced nature of our training dataset. We randomly subsampled the dataset 100 times so that there were exactly the same number of disease-causing and putatively benign variants per gene (2 × 591 variants in total).
Next, we applied the sequential forward selection (SFS) algorithm (Whitney, 1971) to select a feature set for each of the data samples.
Finally, the stability selection creates a stable set of features by selecting those features that SFS repeatedly selected (≥ 25 times) across the 100 samples.
The SFS proceeds as follows. For each sample, the SFS starts with an empty set of features S 0 and iteratively selects a new feature f such that S i = S i−1 ∪ { f } yields the best prediction performance. We adopted the area under the receiver operating characteristic (ROC) curve (AUC, see the next section for definition) to assess prediction performance during feature selection. We let the SFS run until the AUC improvement yielded by increasing the number of features was < 0.005 (so-called early-stop criterion that helps to avoid overtraining).
Evaluation
We employed protein-stratified 10-fold cross-validation to design our method and approximate the prediction performance on the design/training dataset. The 10-fold cross-validation procedure works by dividing the dataset into 10 roughly equally-sized folds. Then, nine folds are merged and used for training, whereas the remaining fold is used for testing. This is repeated 10 times, each time with a different test fold. Finally, the 10 predictions are pooled together. In a proteinstratified cross-validation, it is ensured that the sequence identity of any two proteins from two distinct folds is < 30%. This in turn ensures that a test fold will never comprise a protein similar to the proteins from the folds used for training.
We adopted the ROC curve as the primary evaluation measure For the sake of completeness (Vihinen, 2013) , we also evaluated prediction performance in terms of Matthews correlation coefficient (MCC), classification accuracy (Q 2 ), sensitivity (Se, also referred to as recall), specificity (Sp), positive predictive value (PPV; also referred to as precision), and negative predictive value (NPV). Because these metrics, unlike AUC, are threshold-dependent, we set the prediction threshold for each method so that the MCC of the given method was maximized. The definitions of these metrics can be found in the Supp.
Material.
RESULTS
Discriminating using a single feature
Our design/training dataset contained 318 unique genes with 592 disease-causing (HGMD) and 10,925 putatively benign (1kGP) variants. Such a highly unbalanced dataset simply reflects the real-world situation where a few possible disease-causing variants have to be prioritized for experimental validation among many neutral variants. The 318 genes were carefully selected so that the dataset comprised at least one disease-causing and one benign variant per gene. Having positive and negative variants from the same gene is necessary to avoid the potential bias for specific genes (Grimm et al., 2015) . This in turn allows us to search for features and develop methods for discriminating disease-causing variants rather than disease-associated genes.
Using this design/training dataset, we evaluated 54 diverse features at DNA, RNA, and protein levels (Supp. Table S1 ). The utility of each feature for synonymous variant discrimination was measured using the AUC. The AUC is 1 for perfect discrimination and 0.5 for random discrimination. As shown in Supp. (Altschul et al., 1997) and HHblits (Remmert et al., 2012) ], and protein structural features [protein intrinsic disorder by SPINE-D (Zhang et al., 2012) , and protein secondary structure and solvent accessibility by SPIDER2 (Heffernan et al., 2015) ]. Given that synonymous variants do not alter protein sequences, the lack of strong discriminatory power was expected for the protein-based features but not for some of the DNA-and RNA-based features. , the difference in the predicted exon-inclusion probabilities of the reference and alternative sequences using SPIDEX (Xiong et al., 2015) , and distances from the 3 ′ and nearest splicing sites (exon-intron junctions). The other four features are related to DNA conservation calculated from different multiple-species genomes alignments (Miller et al., 2007) : the AF of the reference allele (rAF cons100 ), difference in the AFs of the variant and that of the reference (ΔAF cons100 ), DNA conservation score (phyloP cons46 ) derived from phylogenetic P values calculated with the phyloP program (Pollard et al., 2010) , and evolutionary rates estimated with a maximum likelihood algorithm (GERP++ cons34 ) (Davydov et al., 2010) .
Figures 1A and 1B depict the distributions of the disease-causing and benign variants for the best RNA-based (MES) and DNA-based (ΔAF cons100 ) features, respectively. Disease-causing variants occurred more frequently when the predicted splice-site motif strength (MES) was high, implying that the variant falls within a splicing motif with a high probability. Regarding ΔAF cons100 , disease-causing variants were characterized by negative values (close to -1), denoting a high AF for the reference allele and a low AF for the variant. Finally, Figure 1C shows the distributions of disease-causing and benign variants in the immediate proximity of the exon-intron junction (1-3 bp), in the larger region commonly considered to be implicated in RNA splicing (4-69 bp), and in the exon core (≥70 bp from the exon-intron junction).
The clear separation shown in this plot explains the high predictive power of naïve features such as the distance to the closest exon-intron junction, which ranked as the third best RNA-based feature with the AUC of 0.705 (Table 2 ). The results summarized in Table 2 and Figure 1 demonstrate that features related to RNA splicing and DNA conservation provide the most discriminative information about the nature of the disease-causing synonymous variants in our dataset.
Combining multiple features with feature selection
Most strongly discriminative single features were related to either DNA conservation or RNA splicing. It is of interest to know whether the weakly discriminative features (when evaluated as single features)
can potentially complement the strongly discriminative features when combined into a predictive nonlinear SVM model (Cortes & Vapnik, 1995) . We employed the stability selection algorithm (Meinshausen & Buhlmann, 2010) to select the most relevant and stable feature combination, avoiding the redundant and most-correlated features. To this end, we created 100 samples from our design/training dataset so that each sample had an equal number of disease-causing and benign variants (thereby ensuring that variant-specific, rather than gene-specific, features would be selected) and performed SFS (Whitney, 1971) Table 2 : MES, |ΔMES|, phyloP cons46 , rAF cons100 , and SPIDEX ΔΨ . The remaining feature with stability > 0.5 but with low AUC of 0.52 was MES-CS, which signifies whether the variant causes a cryptic splice site to become a site with the strongest splicing motif according to MaxEntScan. Thus, while this feature is discriminative only for a subset of all variants (hence the low overall AUC), the feature selection was able to identify its contribution when combined with other predictive features (it was selected 42 out of 100 times). In summary, all selected features were related to either DNA conservation or RNA splicing, in agreement with our single feature analysis.
Comparison with other methods and independent test performance
The ROC curves in Figure 4 show the performance comparison of DDIG-SN with other available methods: a synonymous-specific model-SilVA 1.1.1 (Buske et al., 2013) , conservation score-phyloP cons46way (Pollard et al., 2010) 
F I G U R E 3
The stability metric (reported by stability selection) is compared with the single feature area under the ROC curve (AUC) for the 10 most stable features. The first six features were above the stability threshold of 0.25 and were therefore selected for the DDIG-SN model approach to predict how variants affect splicing-SPIDEX 1.0 (Xiong et al., 2015) .
To further confirm the generality of the DDIG-SN model, we compiled an independent test dataset. This test set comprised a holdout portion of the 279 disease-causing (HGMD) and 4,945 putatively benign (1kGP) variants located in 143 genes whose protein sequence similarity was < 30% compared to any protein in our design/training dataset. On this independent test set, DDIG-SN achieved the highest AUC of 0.85 (Table 3 ; Fig. 4B ), which represents a relative improvement of 2% (P = 0.229, DeLong's test) over the second best method, SilVA, which yielded the AUC of 0.83. Importantly, this independent test performance was close to the DDIG-SN's cross-validation performance (Fig. 4A , AUC of 0.84, a 4% relative improvement as compared to SilVA, P = 5.7 × 10 −5 ) on the dataset used to design our method and optimize all parameters. Hence, DDIG-SN performed robustly, and this evidence suggests that overtraining was avoided. The AUC scores of the other five methods were in the range of 0. 74-0.57 and 0.76-0.59 for the design/training and test datasets, respectively. Supp. Table S2 lists also the Q 2 , Se, Sp, PPV, and NPV scores yielded by all compared methods for both design/training and test datasets. 
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The receiver operating characteristic (ROC) curves of DDIG-SN compared with other available methods: a synonymous-specific model-SilVA, conservation score-phyloP, general approaches for all types of SNVs-FATHMM-MKL, CADD and MutationTaster, and an approach to predict how a variant affects splicing-SPIDEX. A: DDIG-SN was evaluated using protein-stratified 10-fold cross-validation (CV) on the same dataset as used for its design. B: A comparison using an independent test set with < 30% sequence similarity to the design/training dataset. C: A balanced subset of the independent test set in which the closest benign (1kGP) variant was selected for every disease-causing (HGMD) variant (the "close-by" dataset) Both the design/training and test datasets were highly imbalanced with many more benign than disease-causing variants per gene (the overall ratio of 18:1). We were interested in whether DDIG-SN could retain its performance when tested on a fully balanced, more challenging, dataset where for every disease-causing variant, one benign variant was selected so that the genomic distance between the two was as small as possible. We refer to these datasets as "close-by" datasets.
TA B L E 3
As shown in Supp. Figure S1 and Figure 4C , DDIG-SN retained most of its prediction performance with the AUC of 0.83 and 0.84 in crossvalidation and independent testing, respectively. Compared with the second best method, SilVA, DDIG-SN yielded larger relative (as well as absolute) improvements (5%, P = 1.3 × 10 -4 , for cross-validation and 5%, P = 0.008, for the test) than for the general case using the full datasets. Another way of reducing the imbalance in our datasets is by filtering based on the AF for the common (AF ≥ 1%) or rare (AF < 1%) putatively benign variants. While the first helps to reduce the potential false negatives (nonbenign 1kGP variants), the latter shows how accurate the method is for rare variants that cannot be prioritized by comparing with variants from the general healthy population. DDIG-SN retained its prediction performance and relative improvements compared with SilVA for discriminating both common and rare benign variants (Supp .   Table S3 ).
Finally, we evaluated how robustly DDIG-SN performed upon randomly masking 30% of the test data. 
Evaluating predictions based on variant's distance to the exon-intron splice junction
Four of the six features in DDIG-SN are related to alternative splicing. Could this be caused by possible dominance of diseases caused by splicing-related events in our dataset? To examine this possibility, we defined three distinct exonic regions based on the distance to the nearest exon-intron junction: (1) the immediate proximity to the exon-intron junction (1-3 bp), (2) the larger region commonly considered as being implicated in splicing (4-69 bp), and (3) the exon core (≥70 bp from the junction). We selected these three regions as they had been used previously for the analysis of the distribution of human pathogenic variants (Wu & Hurst, 2016) . Table 4 shows the performance of DDIG-SN and the six com- 
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F I G U R E 6 Area under the ROC curve (AUC) of DDIG-SN and RSM (region-specific model) for the three distinct exonic regions defined based on the distance to the nearest exon-intron junction. RSM's AUC scores that were significantly different (P < 0.05, DeLong's test) from DDIG-SN are highlighted using diagonal stripes. The plot demonstrates that the prediction ability of both methods drops with the increased distance to the exon-intron junction mance also for the independent test (AUC of 0.75), its improvement to SilVA (AUC of 0.73) was not significant (P = 0.333).
Apart from comparing DDIG-SN with related work, we wanted to explore whether it was possible to build a more accurate method, dedicated to each of the three exonic regions. Hence, we developed another method, called "Region-Specific Model" (RSM), which comprised three SVM models (RSM 1-3 , RSM 4-69 , and RSM ≥70 ), each optimized for the different region of an exon (1-3, 4-69, and ≥70 bp, respectively). The optimization was performed in terms of splitting the design/training dataset based on the variant's distance to the exon-intron junction and then running the stability feature selection and grid search for optimal SVM hyperparameters on each subset individually. When predicting a test set variant using the RSM method, exactly one of the three models was selected depending upon the distance of the test variant to the exon-intron junction. As shown in Figure 1 , more than 40% of all disease-causing variants in our design/training dataset were found within 3 bp of an exon-intron junction, indicating that the diseasecausing synonymous variants rarely occur further away or in an exon core. The stability metric equals to the fraction of times the particular feature was selected using sequential feature selection (SFS) out of 100 runs on random balanced samples of the training/design dataset. c Stability selection for RSM model comprising variants ≥70 bp from an exon-intron junction resulted in no features with stability ≥ 0.25. Thus, we employed a threshold of 0.15 to be able to train a model for these variants.
we concluded that employing several individually trained models may increase the risk of overtraining, yet it does not offer considerable performance improvements over DDIG-SN.
It is of interest to know whether the RSM selected some interesting features that were specific for the three distinct regions. respectively. Thus, the disease-causing effects in the immediate proximity to exon-intron junctions are driven by the loss of splicing motif strength, whereas the gain of splicing motif strength is the primary cause in regions adjacent to the splice site.
DISCUSSION
We have developed a new method, termed DDIG-SN, for discriminating disease-causing synonymous variants. The method was trained and evaluated using two different datasets with protein sequence identity < 30%. At the same time, each gene had at least one disease-causing and one neutral variant present. This allows for protein-stratified cross-validation and independent testing while ensuring that DDIG-SN was trained for discriminating variants rather than genes, meaning that its performance is a realistic estimate for variants in previously unseen genes. We also minimized overtraining by selecting the most stable six features using the stability selection algorithm (Meinshausen & Buhlmann, 2010) . To this end, we performed 100 SFSs (Whitney, 1971) using 100 randomly created data samples that had an equal number of disease-causing and benign variants per gene, compared to 1:18 ratio of disease-causing to benign variants in the full "real-world" training dataset. The robustness of DDIG-SN is evident from the similar performance between 10-fold cross-validation and the independent test (Table 3) , stable performance upon randomly masking 30% of the test data (Fig. 5 ) as well as using only the common (AF ≥ 1%), rare (AF < 1%), or "close-by" putatively benign 1kGP variants (Supp. Table   S3 ; Fig. 4C ). More importantly, DDIG-SN had the best performance among all the methods compared across different datasets.
Synonymous variants have a direct effect only on the DNA and RNA sequences. Thus, it is expected that the protein-based features would not be useful for the discrimination of synonymous variants.
However, it has been observed that synonymous variants can impact both structure and function of the protein (Kimchi-Sarfaty et al., 2007; Montera et al., 2001; Zhou et al., 2013) . Thus, it is necessary to examine some of the protein-based features that have been found to be important in discriminating nonsynonymous variants that result in single amino acid substitutions (Adzhubei et al., 2010; Folkman et al., 2016) , nonsense variants that introduce premature termination codons (Folkman et al., 2015) , and indels that lead to the addition or removal of a short segment of amino acid residues (nonframeshifting indels) (Bermejo-Das-Neves, Nguyen, Poch, & Thompson, 2014; Zhao et al., 2013) or randomization of the protein sequence (frameshifting indels) (Douville et al., 2016; Folkman et al., 2015; Hu & Ng, 2012) . To this end, we analyzed the sequence and structural features related to protein sequence conservation derived from PSI-BLAST (Altschul et al., 1997) and HHblits (Remmert et al., 2012) , protein intrinsic disorder predicted with SPINE-D (Zhang et al., 2012) , and protein secondary structure and solvent accessibility predicted with SPIDER2 (Heffernan et al., 2015) . All these features yielded a marginal discriminative power (AUC < 0.54) when evaluated individually. Moreover, they were not selected during the feature selection for the final SVM model. This result supports the notion that changes in the protein structure and function are likely the secondary effects of the changes in the RNA/DNA sequence.
When analyzing the selected DNA-and RNA-level features, we found that DDIG-SN model was dominated by features related to RNA splicing (four out of six features in total). This confirms the damaging role of synonymous variants in RNA splicing found in many studies (Buske et al., 2013; Li et al., 2017; Xiong et al., 2015; ). Here, we were able to show that while the loss of splicing motif strength is the most robust predictive feature in the immediate neighborhood of the exon-intron junction (1-3 bp), it is the gain of splicing motif strength that is important for the region adjacent to the splice site (4-69 bp).
The key features other than splicing relate to DNA sequence conservation. The evolutionary conservation of DNA sequence can be due to a structural or functional requirement at either the DNA or RNA level. To clear up the ambiguity, we removed all features related to evolutionary conservation and performed the feature selection again. Then, all selected features were related to splicing (Supp. Table S4 ).
The lack of mRNA structure-related features [secondary structure folding energy (Markham & Zuker, 2008) , ensemble diversity (Lorenz et al., 2011) , and solvent-accessible surface area ], despite ample experimental evidence for their role in translation and transcription (Mortimer, Kidwell, & Doudna, 2014; Wan et al., 2014) , could reflect the challenge in predicting RNA structural properties accurately, in particular, in the absence of their interacting partners, irrespective of whether it is at the secondary or tertiary level (Hajdin et al., 2013; Miao et al., 2015; Seetin & Mathews, 2012) . Another feature that was not selected was the possible formation or disruption of G-quadruplexes due to synonymous variants. It had a near random AUC score as a single feature (AUC = 0.502) despite the occurrence of G-quadruplexes that have been implicated in neurodegenerative diseases and the noncoding transcriptome (Rhodes & Lipps, 2015; Simone, et al., 2015) . In addition, variant-induced changes in binding affinities of DNA-and RNA-binding proteins were not selected, despite ample evidence of their regulatory roles (Dreyfuss et al., 2002; Stergachis et al., 2013) . Possible reasons for this could be: first, inaccuracy of the employed (state-of-the-art) prediction methods, second, limited size of the disease-causing synonymous variants dataset from the HGMD, and third, binding disrupted at one site may be compensated for at another site.
The limited prediction performance of all evaluated methods for synonymous variants in exon cores (≥70 bp away from exon-intron junction) suggests that there are unknown features, not considered by any of the methods. Possibly, a more sensitive prediction of RNA and protein structural features, which could predict not only the wild type but also the structural changes induced by genetic variations, could help improve predictions in these regions. Additionally, more accurate models of the functional impact of genetic variants, such as "compensation-aware" models of RNA-and DNA-binding proteins affinity changes, are needed.
